STAT+: Pharmalittle: U.S. trade rep to talk with WTO about IP and Covid-19 vaccines; WHO’s Tedros plans to seek re-election
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Category: Pharmalot
STAT+: Brazilian senate votes to suspend patents in bid to widen access to Covid-19 vaccines
After a year of politicking, the Brazilian senate passed a bill that would permit the…
STAT+: Pharmalittle: Wyden goes back to the drawing board on drug pricing; Emergent undergoes an executive shake-up
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Did someone say patent thicket? AbbVie CEO to testify before Congress about drug pricing tactics
As part of its probe into pharmaceutical industry pricing tactics, a Congressional committee next month…
STAT+: Global spending on medicines could hit $1.6 trillion by 2025 — and that doesn’t include Covid-19 vaccines
Global spending on medicines is forecast to grow between 3% and 6% annually and reach…
STAT+: Pharmalittle: Biden issues ’empty call’ for drug pricing reform; FDA threatens to fine company for not posting trial results
Top of the morning to you, and a fine one it is. Gray skies are…
STAT+: Americans paid two to four times as much for some drugs as in three other countries
Amid national angst over the cost of prescription drugs, a new analysis finds that U.S….
STAT+: For the first time, the FDA may fine a drug maker for failing to post clinical trial results
The Food and Drug Administration is threatening to fine Acceleron Pharma (XLRN) for failing to…
STAT+: Pharmalittle: Pfizer Covid-19 pill could be ready by year-end; Warren urges SEC to probe Emergent CEO over stock sales
Hello, everyone, and welcome to the middle of the week. You made it this far,…
STAT+: Will India issue sidestep patents on a pair of pricey — but lifesaving — TB drugs?
A widely anticipated court hearing will be held in India on Wednesday over the cost…
.jpg)
Biogen to expand access to its ALS drug, but move may come too late for some patients
After weeks of controversy, Biogen (BIIB) has agreed to provide an experimental drug for combating…
STAT+: Pharmalittle: What will Biden say about drug pricing? U.S. trade rep meets with drug makers over WTO proposal
Rise and shine, folks, another busy day is on the way. We can tell because,…
STAT+: Thanks to its Covid-19 response, pharma’s reputation among patient groups is climbing
Thanks to the rapid development of Covid-19 vaccines, nearly two-thirds of patient advocacy groups believe…
STAT+: U.K. lawmakers want Boris Johnson to disclose emails with pharma about a WTO proposal on Covid-19 vaccines
Two dozen U.K. lawmakers called on the government to publish all communications with drug makers…
STAT+: Down and out Down Under? Bristol Myers fights an ‘unreasonable’ Australian law over patents
Two big drug makers are challenging a provision in Australian patent law that they argue…
STAT+: Pharmalittle: Emergent CEO sold stock before vaccine contamination was reported; Biden urged to support WTO proposal
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Millions sign petitions urging the U.S. to back a WTO proposal for greater Covid-19 vaccine access
More than two million petitions were sent to the White House in hopes of convincing…
STAT+: The price of a Vertex cystic fibrosis treatment stirs anger in Australia
The latest dustup over the cost of cystic fibrosis medicines sold by Vertex Pharmaceuticals (VRTX)…
STAT+: Pharmalittle: CDC committee to vote on J&J Covid-19 vaccine; has the White House written off the J&J shot?
And so, another working week will soon draw to a close. Not a moment too…
STAT+: ‘There are no alternatives’: As Pfizer discontinues an old glaucoma drug, a small group of patients struggles to cope
Next month, an eye drop that Carol Vaghar has taken for the past few years…
STAT+: Pharmalittle: Europe looks to sue AstraZeneca over Covid-19 vaccine shortfalls; FDA skewers Emergent vaccine facility
Hello, everyone, and how are you today? Cold winds are whipping about the Pharmalot campus,…
STAT+: FDA issues scathing report of Emergent plant responsible for contaminated Covid-19 vaccines
The Food and Drug Administration issued a scathing inspection report of the Emergent BioSolutions (EBS)…
STAT+: Pharmalittle: Pfizer identifies first counterfeit versions of its Covid-19 vaccine; top house Democrats investigate Emergent BioSolutions
Rise and shine, everyone, another busy day is on the way. This is the middle…
Most Americans say they should be vaccinated before the U.S. donates Covid-19 shots elsewhere
Three-quarters of Americans believe the U.S. government should start donating Covid-19 vaccines to other countries,…
STAT+: Congress probes Emergent’s ties to a key Trump official in wake of Covid-19 vaccine scandal
A pair of top House Democrats is investigating whether Emergent BioSolutions (EBS), which was responsible…
STAT+: Pfizer shareholders are urged to reject political spending that contradicts ‘company values’
Arguing that Pfizer’s political spending conflicts with the company’s publicly stated values, a philanthropic organization…
STAT+: Pharmalittle: Biden aides met with U.S. health companies about supply chains; J&J Covid-19 shot notched $100m in sales
Hello, everyone, and how are you today? A shiny sun and delightful breeze are enveloping…
STAT+: Pharmalittle: J&J denies design of its Covid-19 shot may explain blood clots; second trial against opioid makers begins
Good morning, everyone, and welcome to another working week. Once again, another delightful weekend respite…
STAT+: Advocacy groups outraged after PBM offers a $500 gift card to persuade patients to switch drugs
Dozens of patient advocacy groups are angry over an unusual move by a pharmacy benefits…
STAT+: Pharmalittle: J&J rivals rebuff bid to jointly study Covid-19 vaccine risks; will next-gen Covid shots be better or worse?
And so, another working week will soon draw to a close. Not a moment too…
STAT+: A drug maker sues a medical journal, its editor, and several authors for libel
In an unusual move, Pacira Biosciences (PCRX) has filed a libel lawsuit against a medical…
STAT+: WTO head urges movement on controversial Covid-19 vaccine proposal, but objections remain
Amid mounting pressure to widen global access to Covid-19 vaccines, the head of the World…
STAT+: Pharmalittle: Pause for J&J Covid-19 shot to continue at least a week; Biden expands candidate list for FDA commish
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: WHO warns the world is still failing to develop desperately needed antibiotics
Despite mounting concern over antibiotic resistance, a new report finds that none of 43 antibiotics…
STAT+: FDA is urged to move faster to list medicines withdrawn over safety concerns
Arguing patient safety is at risk, an advocacy group is urging the Food and Drug…
STAT+: Pharmalittle: Pfizer to boost Covid-19 vaccine production for the U.S.; J&J faces new test with Covid-shot pause
Hello, everyone, and welcome to the middle of the week. You made it this far,…
STAT+: A U.S. appeals court upholds the FTC view of controversial pay-to-delay settlements
In what is being called a win for consumers, a U.S. appeals court upheld a…
STAT+: Pharmalittle: U.S. urges states to pause J&J Covid-19 shots; PhRMA’s new message says ‘Don’t take us for granted’
Rise and shine, another busy day is on the way. However, this is also shaping…
STAT+: Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time
In a bid to lower prescription drug costs, a federal agency is recommending pharmaceutical companies…
STAT+: Pharmalittle: Regeneron antibody reduced Covid-19 infection risk; variant first seen in South Africa can somewhat ‘break through’ Pfizer shot
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Clinical study reports hold more details about the side effects of cancer drugs
For years, researchers have urged regulators to release clinical study reports that are generated during…
STAT+: Pharmalittle: Lilly arthritis drug failed main goal in Covid-19 study; Serum Institute asks India for a big grant to make Covid shots
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Brazilian judge temporarily suspends pharmaceutical patent extensions amid push to lower drug costs
A Brazilian Supreme Court judge suspended extensions for pharmaceutical patents in the country, and although…
STAT+: Pharmalittle: EMA finds link between AstraZeneca shot and rare blood clots; life science private financing is at record levels
Rise and shine, another busy day is on the way. However, this is also shaping…
Judge rules Purdue must answer questions about documents showing any link between OxyContin, birth defects
A federal judge has given a green light to lawyers representing children with birth defects…
STAT+: Merck reaches deal with Austrian antitrust regulators over ‘predatory’ pricing for a cancer drug
Following a three-year probe, Merck (MRK) reached a deal with Austrian regulators to end a…
STAT+: Pharmalittle: U.S. is prohibited from sharing Covid-19 shots with other countries; U.S. officials knew of problems at Emergent plant
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: A controversial court case in Brazil will tackle pharma ‘monopolies’ and access to drugs
After years of anticipation, the Brazilian Supreme Court is holding a hearing this week on…
STAT+: California once again delays launch of a closely watched prescription drug purchasing program
For the second time this year, California officials have delayed a much-ballyhooed effort to start…
STAT+: Pharmalittle: EMA official says link exists between AstraZeneca Covid-19 shot and rare blood clots; Catalent to boost Moderna vaccine production
Top of the morning, and a fine one it is. Clear blue skies and a…